BioNTech acquires a former Novartis manufacturing facility in Singapore

Pfizer’s mRNA vaccine partner BioNTech is spreading its manufacturing reach across the globe, with its latest foothold in Southeast Asia. BioNtech announced on Monday that its Singapore-based affiliate, BioNTech Pharmaceuticals Asia Pacific Pte. Ltd., had entered into an agreement with Novartis to acquire a GMP manufacturing facility in the country,

Read the full article here

Related Articles